Login / Signup

Early Postmortem Beef Muscle Proteome and Metabolome Variations Due to Supranutritional Zinc and Ractopamine Hydrochloride Supplementation.

Matthew D SchulteKatherine G HochmuthEdward M SteadhamSteven M LonerganStephanie L HansenElisabeth Huff-Lonergan
Published in: Journal of animal science (2024)
It was hypothesized that the longissimus thoracis (LT) muscle proteome, phosphoproteome, and metabolome could explain postmortem metabolism and tenderness differences in muscle from cattle supplemented zinc (Zn) and/or ractopamine hydrochloride (RH). High percentage Angus steers (N=20) were fed in a 2x2 factorial assigned to Zn and RH treatments: control (CON; n=10; analyzed 36 mg Zn/kg dry matter [DM]) or supranutritional Zn supplementation (SUPZN; n=10; control diet + 60 mg Zn/kg DM [from ZnSO4] + 60 mg Zn/kg DM [from Zn-amino acid complex]) for the entire 89-d trial. During the 28 d before harvest, steers were blocked by body weight within Zn treatments to RH treatments of 0 (NO; n=10) or 300 mg (RAC; n=10) per steer per day. Steers were harvested at the Iowa State Meat Laboratory, where pH decline (1, 3, 6, and 24 h postmortem) was measured. At 24 h postmortem, LT muscle sections were removed from carcasses, and steaks were analyzed for Warner-Bratzler shear force (WBSF) values at 1, 3, 7, and 14 d postmortem. Muscle samples were taken at 1 h, 1, 3, 7, and 14 d postmortem for the following analysis: troponin-T degradation (1, 3, 7, and 14 d postmortem), myosin heavy chain (MHC) analysis (1 h postmortem), sarcoplasmic proteome analysis through tandem mass tagging analysis (TMT; 1 h and 1 d postmortem), metabolome analysis (1 h and 1 d postmortem), and phosphoproteome analysis (1 h postmortem). SUPZN-NO tended to have a lower (P=0.06) pH at 6 h postmortem and a lower WBSF value (P=0.06) at 1 d postmortem. CON-RAC had a higher (P=0.04) pH at 6 h postmortem and WBSF value (P<0.01) at 1 d postmortem. A lower pH at 6 h postmortem and lower WBSF value at 1 d postmortem in the SUPZN-NO treatment was accompanied by more sorbitol and fructose at 1 d postmortem, and less myosin regulatory light chain 2 at 1 h postmortem, and less adenosine monophosphate deaminase 1 (AMPD1) at 1 d postmortem than all other treatments. A higher pH at 6 h postmortem and higher WBSF value at 1 d postmortem in CON-RAC and SUPZN-RAC was accompanied by more soluble structural proteins (troponin-T and myosin-7) at 1 h postmortem than CON-NO. At 1 h postmortem, CON-RAC had more glyceraldehyde-3-phosphate dehydrogenase than CON-NO or SUPZN-RAC. Differences in energy metabolism enzymes, metabolites, and structural proteins may affect ATP production, rigor development, and lactate buildup which may explain the differences in postmortem metabolism and tenderness development at 1 d postmortem.
Keyphrases
  • randomized controlled trial
  • clinical trial
  • heavy metals
  • risk assessment
  • body weight
  • transcription factor
  • open label
  • phase iii
  • phase ii